$MTNB Income Statement | Understand Stock

$MTNB

$1.91 +$0.08 (4.37%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Contract Revenue
Costs and Expenses:
Research and development
General and administrative
Impairment charges of goodwill and other intangible assets
Impairment charges of other assets
Total costs and expenses
Loss from operations
Sale of New Jersey net operating loss & tax credits
Other income, net
Change in fair value of warrant liability
Gain on sale of assets
Other (expenses)/income, net
Loss before tax
Income tax benefit
Net loss
Preferred stock series B accumulated dividends
Deemed dividend relating to warrant exchange
Net loss attributable to common shareholders
Net loss attributable to common shareholders per share – basic and diluted
Basic and diluted
Net loss per share - basic
Net loss per share - diluted
Weighted average common shares outstanding - basic
Weighted average common shares outstanding - diluted
Other comprehensive gain, net of tax
Net unrealized gain on securities available-for-sale
Other comprehensive gain, net of tax
Comprehensive loss

Comments